Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Prevalence of Human Papillomavirus and Co-Existent Sexually Transmitted Infections among Female Sex Workers, Men having Sex with Men and Injectable Drug abusers from Eastern India

  • Ghosh, Ishita (STD Lab, Institute of Serology, Chittaranjan National Cancer Institute) ;
  • Ghosh, Pramit (Department of Preventive Medicine, Medical College, Chittaranjan National Cancer Institute) ;
  • Bharti, Alok Chandra (Institute of Cytology & Preventive Oncology, Chittaranjan National Cancer Institute) ;
  • Mandal, Ranajit (Department of Gynaecological Oncology, Chittaranjan National Cancer Institute) ;
  • Biswas, Jaydip (Department of Surgical Oncology, Chittaranjan National Cancer Institute) ;
  • Basu, Partha (Department of Gynaecological Oncology, Chittaranjan National Cancer Institute)
  • Published : 2012.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Human papillomavirus (HPV) is a very common sexually transmitted disease affecting both men and women and is responsible for different ano-genital cancers in either sex. Co-existing sexually transmitted infections (STI) including HIV have been considered as important co-factors for carcinogenesis induced by HPV. The purpose of this study was to determine the prevalence of any HPV, HPV 16 and HPV 18 and also concomitant STIs among female sex workers (FSW), men having sex with men (MSM) and injectable drug users (IDU). Material and Method: This cross-sectional study was conducted among 45 FSWs, 26 MSMs and 58 IDUs who attended the STI or de-addiction clinics. Genital scrape samples collected from glans penis and coronal sulcus in males and cervical squamo-columnar junction in females were tested for HPV DNA by PCR using HPV L1 consensus primer. Type specific PCR to detect HPV 16 and 18 was done on the samples positive on consensus PCR. All participants were tested for associated STIs including HIV and hepatitis B and cervical cytology was done on all females. Results: Among the FSWs, HPV was detected in 73.3% and HPV 16 and 18 was detected in 25.7%. Though the HPV prevalence was similarly high among MSMs (69.2%) and IDUs (72.4%), the prevalence of HPV 16 and 18 was much lower in these groups compared to the FSWs. Prevalence of cervico-vaginal infection with Trichomonas vaginalis and syphilis was significantly higher in the HPV positive women compared to the HPV negative women. There was no statistically significant difference in the prevalence of other STIs among HPV positive and negative women and men. Conclusion: HPV infection is highly prevalent among FSW, MSM and IDUs. Trichomonas vaginalis infection is more frequent in HPV positive women.

Keywords

References

  1. Bulhak-Koziol V, Zdrodowska-Stefanow B, Ostaszewska-Puchalska I, et al (2007). Prevalence of Chlamydia trachomatis infection in women with cervical lesions. Adv Med Sci, 52, 179-81.
  2. Koutsky L (1997). Epidemiology of genital human papillomavirus infection. Am J Med, 102, 3-8.
  3. Palefsky JM, Minkoff H, Kalish LA, et al (1999). Cervicovaginal human papillomavirus infection in human immunodeficiency vrus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst, 91, 226-9. https://doi.org/10.1093/jnci/91.3.226
  4. Sarkar K, Bhattacharya S, Bhattacharya S, et al (2008). Oncogenic human papilloma virus and cervical pre-cancerous lesions in brothel based sex workers in India. J Infect Public Health, 1, 121-8. https://doi.org/10.1016/j.jiph.2008.09.001
  5. Sarkar K, Pal R, Bal B, et al (2011). Oncogenic HPV among HIV infected female population in West Bengal, India. BMC Infect Dis, 11, 72-8. https://doi.org/10.1186/1471-2334-11-72
  6. Schlott T, Eiffert H, Bohne W, et al (2005). Chlamydia trachomatis modulates expression of tumor suppressor gene caveolin-1 and oncogene C-myc in the transformation zone of non-neoplastic cervical tissue. Gynecol Oncol, 98, 409-19. https://doi.org/10.1016/j.ygyno.2005.04.034
  7. Solomon D, Davey D, Kurman R, et al (2002). The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA, 287, 2114-9. https://doi.org/10.1001/jama.287.16.2114
  8. Szostek S, Zawilinska B, Kopec J, Kosz-Vnenchak M (2009). Herpesviruses as possible cofactors in HPV-16-related oncogenesis. Acta Biochim Pol, 56, 337-42.
  9. Viikki M, Pukkala E, Nieminen P, Hakama M (2000). Gynaecological infections as risk determinants of subsequent cervical neoplasia. Acta Oncol, 39, 71-5. https://doi.org/10.1080/028418600431003
  10. Yliskoski M, Tervahauta A, Saarikoski S, Mantyjarvi R, Syrjanen K (1992). Clinical course of cervical human papillomavirus lesions in relation to coexistent cervical infections. Sex Transm Dis, 19, 137-9. https://doi.org/10.1097/00007435-199205000-00005
  11. Zhang ZF, Begg CB (1994). Is Trichomonas vaginalis a cause of cervical neoplasia? Results from a combined analysis of 24 studies. Int J Epidemiol, 23, 682-90. https://doi.org/10.1093/ije/23.4.682

Cited by

  1. The Role of Human Papillomavirus in Human Immunodeficiency Virus Acquisition in Men who Have Sex with Men: A Review of the Literature vol.4, pp.12, 2012, https://doi.org/10.3390/v4123851
  2. The diversity of human papillomavirus infection among human immunodeficiency virus-infected women in Yunnan, China vol.11, pp.1, 2014, https://doi.org/10.1186/s12985-014-0202-3
  3. Prevalence of Abnormal Anal Cytology in HIV-Infected Women: a Hospital-Based Study vol.15, pp.15, 2014, https://doi.org/10.7314/APJCP.2014.15.15.6405
  4. Anal Papanicolaou Smear in Women with Abnormal Cytology: a Thai Hospital Experience vol.16, pp.3, 2015, https://doi.org/10.7314/APJCP.2015.16.3.1289
  5. Reproductive Tract infections and Premalignant Lesions of Cervix: Evidence from Women Presenting at the Cancer Detection Centre of the Indian Cancer Society, Delhi, 2000–2012 vol.66, pp.S1, 2016, https://doi.org/10.1007/s13224-015-0819-1
  6. Are vaginal swabs comparable to cervical smears for human papillomavirus DNA testing? vol.29, pp.1, 2018, https://doi.org/10.3802/jgo.2018.29.e8